Anita W. Rijneveld

Internist-hematologist
Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands
Rotterdam, Zuid-Holland, Netherlands

Presentation(s):

• OC 32.3 - Low-molecular-weight heparin for the prevention of venous thromboembolism in adults with newly diagnosed acute lymphoblastic leukemia; prospective side-study of the HOVON-100 trial

  Monday, June 24, 2024
  10:00 – 10:15 ICT